Experimental Hematology
Volume 38, Issue 6 , Page 435 , June 2010

Platelet-activating factor and acute myelogenous leukemia

  • Yves Denizot

      Affiliations

    • Corresponding Author InformationOffprint requests to: Yves Denizot, Ph.D., Faculté de Médecine, UMR CNRS 6101, 2 rue Dr. Marcland, 87025 Limoges, France.

References 

  1. Cellai C, Laurenzana A, Bianchi E, et al. Mechanistic insight into WEB-2170-induced apoptosis in acute myelogenous leukemia cells: the crucial role of PTEN. Exp Hematol. 2009;37:1176–1185
  2. Denizot Y, Rougier F, Dupuis F, et al. Biosynthesis and metabolism of PAF by human bone marrow stromal cells. Exp Hematol. 1996;24:1327–1332
  3. Dupuis F, Desplat V, Praloran V, Denizot Y. Effect of lipidic mediators on the growth of human myeloid and erythroid progenitors. J Lipid Mediat Cell Signal. 1997;16:117–125
  4. Dupuis F, Levasseur S, Jean-Louis F, et al. Production, metabolism and effect of platelet-activating factor on the growth of the human K562 erythroid cell line. Biochim Biophys Acta. 1997;1359:241–249
  5. Donnard M, Guglielmi L, Turlure P, et al. Membrane and intracellular platelet-activating factor receptor expression in leukemic blasts of patients with acute myeloid and lymphoid leukemia. Stem Cells. 2002;20:394–401
  6. Reynaud S, Malissein E, Donnard M, et al. Functional platelet-activating factor receptors in immature forms of leukemic blasts. Leukemia Res. 2007;31:399–402
  7. Truffinet V, Vincent C, Donnard M, et al. No effect of platelet-activating factor on the proliferation and apoptosis of immature forms of leukemic blasts. Leukemia Res. 2007;31:1766–1768

PII: S0301-472X(10)00099-8

doi: 10.1016/j.exphem.2010.03.008

Experimental Hematology
Volume 38, Issue 6 , Page 435 , June 2010

Article Tools